ArticleOncotarget2018

The combination of everolimus and zoledronic acid increase the efficacy of gemcitabine in a mouse model of pancreatic adenocarcinoma.

Carole Vitellius et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.